Insulin-like growth factor-independent effects of growth hormone on growth plate chondrogenesis and longitudinal bone growth

Endocrinology (United States)

Volumn 156, Issue 7, 2015, Pages 2541-2551

  Wu, Shufang ^a,b   Yang, Wei ^b   De Luca, Francesco ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 10; CYTOMEGALOVIRUS ANTIGEN PP65; GROWTH HORMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 2; MESSENGER RNA; SMALL INTERFERING RNA; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR; TAMOXIFEN; BMP2 PROTEIN, MOUSE; JAK2 PROTEIN, MOUSE; RELA PROTEIN, MOUSE; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR RELA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY GROWTH; BODY HEIGHT; BONE GROWTH; CARTILAGE CELL; CHONDROGENESIS; CONTROLLED STUDY; DNA SYNTHESIS; EMBRYO; ENZYME PHOSPHORYLATION; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GENE DELETION; GENE EXPRESSION; GENETIC TRANSFECTION; GENOTYPE; GROWTH PLATE; INTRACELLULAR TRANSPORT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; BONE; BONE DEVELOPMENT; CELL CULTURE; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHOSPHORYLATION;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEIN 2; CELLS, CULTURED; CHONDROCYTES; CHONDROGENESIS; COLLAGEN TYPE X; GROWTH HORMONE; GROWTH PLATE; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; JANUS KINASE 2; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; TRANSCRIPTION FACTOR RELA;

EID: 84937562821     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1983     Document Type: Article

References (60)

1. Ohlsson C, Bengtsson BA, Isaksson OGP, Andreassen TT, Slootweg MC. Growth hormone and bone. Endocr Rev. 1998;19(1):55-79.
2. Butler AA, Le Roith D. Control of growth by the somatotropic axis: growth hormone and insulin-like growth factors have related and independent roles. Annu Rev Physiol. 2001;63:141-164.
3. Salmon WD, Daughaday WH. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med. 1957;49(6):825-836.
4. Ellis S, Huble J, Simpson ME. Influence of hypophysectomy and growth hormone on cartilage sulfate metabolism. Proc Soc Exp Biol Med. 1953;84(3):603-605.
5. Daughaday WH, Reeder C. Synchronous activation of DNA synthesis in hypophysectomized rat cartilage by growth hormone. J Lab Clin Med. 1966;68(3):357-368.
6. Daughaday WH, Hall K, Raben MS, Salmon WD Jr, Van der Brande JL, Van Wyk JJ. Somatomedin: proposed designation for sulphation factor. Nature. 1972;235(5333):107.
7. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev. 1989;10(1):68-91.
8. Daughaday D. Growth hormone and the somatomedins. In: Daughaday D, ed. Endocrine Control of Growth. New York: Elsevier; 1981:1-24.
9. D'Ercole AJ, Applewhite GT, Underwood LE. Evidence that somatomedin is synthesized by multiple tissues in the fetus. Dev Biol. 1980;75(2):315-328.
10. Kajimoto Y, Rotwein P. Structure and expression of a chicken insulin-like growth factor I precursor. Mol Endocrinol. 1989;3(12):1907-1913.
11. Roberts CT Jr, Lasky SR, Lowe WL Jr, Seaman WT, LeRoith D. Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. Mol Endocrinol. 1987;1(3):243-248.
12. Han VK, Lund PK, Lee DC, D'Ercole AJ. Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution. J Clin Endocrinol Metab. 1988;66(2):422-429.
13. Isaksson OG, Jansson JO, Gause IA. Growth hormone stimulates longitudinal bone growth directly. Science. 1982;216(4551):1237-1239.
14. Russell SM, Spencer EM. Local injections of human or rat growth hormone or of purified human somatomedin C stimulate unilateral tibial epiphyseal growth in hypophysectomized rats. Endocrinology. 1985;116(6):2563-2567.
15. Schlechter NL, Russell SM, Spencer EM, Nicoll CS. Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc Natl Acad Sci USA. 1986;83(20):7932-7934.
16. Isaksson OG, Lindahl A, Nilsson A, Isgaard J. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev. 1987;8(4):426-438.
17. Govoni KE, Lee SK, Ching YS, et al. Disruption of insulin-like growth factor-I expression in type II αI collagen-expressing cells reduces bone length and width in mice. Physiol Genomics. 2007;30:354-362.
18. Yakar S, Liu JL, Stannard B, et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA. 1999;96(13):7324-7329.
19. Sjogren K, Liu JL, Blad K, et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA. 1999;96(12):7088-7092.
20. Wang J, Zhou J, Bondy CA. Igf1 promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy. FASEB J. 1999;13(14):1985-1990.
21. Wang J, Zhou J, Cheng CM, Kopchick JJ, Bondy CA. Evidence supporting dual, IGFI-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth. J Endocrinol. 2004;180(2):247-255.
22. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A. Roles of growth hormone and insulin-like growth factor I in mouse postnatal growth. Dev Biol. 2001;229(1):141-162.
23. Dietrich P, Dragatsis I, Xuan S, Zeitlin S, Efstratiadis A. Conditional mutagenesis in mice with heat shock promoter-driven cre transgenes. Mamm Genome. 2000;11(3):196-205.
24. Metzger D, Li M, Chambon P. Targeted somatic mutagenesis in the mouse epidermis. Methods Mol Biol. 2005;289:329-340.
25. Nakamura E, Nguyen MT, Mackem S. Kinetics of tamoxifen-regulated Cre activity in mice using a cartilage-specific CreER(T) to assay temporal activity windows along the proximodistal limb skeleton. Dev Dyn. 2006;235(9):2603-2612.
26. Zhang M, Xuan S, Bouxsein ML, et al. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem. 2002;277(46):44005-44012.
27. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101-1108.
28. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 1993;75(1):73-82.
29. Liu JL, Grinberg A, Westphal H, et al. Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Mol Endocrinol. 1998;12(9):1452-1462.
30. Powell-Braxton L, Hollingshead P, Warburton C, et al. IGF-I is required for normal embryonic growth in mice. Genes Dev. 1993;7(12B):2609-2617.
31. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med. 1996;335(18):1363-1367.
32. Bonapace G, Concolino D, Formicola S, Strisciuglio P. A novel mutation in a patient with insulin-like growth factor 1 (IGF-1) deficiency. J Med Genet. 2003;40(12):913-917.
33. Walenkamp MJ, Karperien M, Pereira AM, et al. Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab. 2005;90(5):2855-2864.
34. Netchine I, Azzi S, Le Bouc Y, Savage MO. IGF-1 molecular anomalies demonstrate its critical role in fetal, postnatal growth and brain development. Best Pract Res Clin Endocrinol Metab. 2011;25(1):181-190.
35. Yakar S, Rosen CJ, Beamer WG, et al. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest. 2002;110(6):771-781.
36. Clark R, Carlsson L, Mortensen D, Cronin M. Additive effects on body growth of insulin-like growth factor-I and growth hormone in hypophysectomized rats. Endocrinol Metab. 1994;1:49-54.
37. Clark R, Mortensen D, Carlsson L. Insulin-like growth factor-I and growth hormone (GH) have distinct and overlapping effects in GH-deficient rats. Endocrine. 1995;3(4):297-304.
38. Fielder PJ, Mortensen DL, Mallet P, Carlsson B, Baxter RC, Clark RG. Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats. Endocrinology. 1996;137(5):1913-1920.
39. LeRoith D, Yanowski J, Kaldjian EP, et al. The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys. Endocrinology. 1996;137(3):1071-1079.
40. DeChiara TM, Efstradiatis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature. 1990;345(6270):78-80.
41. Giannaoukakis N, Deal C, Paquette J, Goodyer CG, Polychronakos C. Parental genomic imprinting of the human IGF2 gene. Nat Genet. 1993;4(1):98-101.
42. Parker EA, Hedge A, Buckley M, Barnes KM, Baron J, Nilsson O. Spatial and temporal regulation of GH-IGF-related gene expression in growth plate cartilage. J Endocrinol. 2007;194(1):31-40.
43. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev. 1995;16(2):143-163.
44. Beukers MW, OH Y, Zhang H, Ling N, Rosenfeld RG. [Leu27] insulin-like growth factor II is highly selective for the type II IGF receptor in binding, cross-linking and thymidine incorporation experiments. Endocrinology. 1991;128(2):1201-1203.
45. Furlanetto RW, DiCarlo JN, Wisehart C. The type II insulin-like growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts. J Clin Endocrinol Metab. 1987;64(6):1142-1149.
46. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the gene encoding insulin-like growth factor I (Igf1) and type 1 IGF receptor (IGFr). Cell. 1993;75(1):59-72.
47. Efstradiatis A. Genetics of mouse growth. Int J Dev Biol. 1998;42(7):955-976.
48. Louvi A, Accili D, Efstratiadis A. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol. 1997;189:33-48.
49. Walenkamp MJE, Losekoot M, Wit JM. Molecular IGF-1 and IGF-1 receptor defects: from genetics to clinical management. Endocr Dev. 2013;24:128-137.
50. Fang P, Hi Cho Y, Derr MA, Rosenfeld RG, Hwa V, Cowell CT. Severe short stature caused by novel compound heterozygous mutation of the insulin-like growth factor 1 receptor (IGF1R). J Clin Endocrinol Metab. 2012;97:E243-E247.
51. Hansen TK, Thiel S, Dall R, et al. GH strongly affects serum concentrations of mannan-binding lectin: evidence for a new IGF-I independent immunomodulatory effect of GH. J Clin Endocrinol Metab. 2001;86(11):5383-5388.
52. Li G, del Rincon JP, Jahn LA, et al. Growth hormone exerts acute vascular effects independent of systemic or muscle insulin-like growth factor I. J Clin Endocrinol Metab. 2008;93(4):1379-1385.
53. Sotiropoulos A, Ohanna MI, Kedzia C, et al. Growth hormone promotes skeletal muscle cell fusion independent of insulin-like growth factor 1 up-regulation. Proc Natl Acad Sci USA. 2006;103(19):7315-7320.
54. DiGirolamo DJ, Mukherjee A, Fulzele K, et al. Mode of growth hormone action in osteoblasts. J Biol Chem. 2007;282(43):31666-31674.
55. Wang Y, Cheng Z, ElAlieh HZ, et al. IGF-1R signaling in chondrocytes modulates growth plate development by interacting with the PTHrP/Ihh pathway. J Bone Miner Res. 2011;26(7):1437-1446.
56. Wu S, Flint JK, Rezvani G, De Luca F. Nuclear factor-κB p65 facilitates longitudinal bone growth by inducing growth plate chondrocyte proliferation and differentiation and by preventing apoptosis. J Biol Chem. 2007;282(46):33698-33706.
57. Wu S, Morrison A, Sun H, De Luca F. NF-κB p65 mediates the effects of growth hormone on longitudinal bone growth, growth plate chondrogenesis, and insulin-like growth factor-1 synthesis. J Biol Chem. 2011;286(28):24726-24734.
58. Mul D, Wu S, de Paus RA, et al. A mosaic de novo duplication of 17q21-25 is associated with GH insensitivity, disturbed in vitro CD28-mediated signaling, and decreased STAT5B, PI3K, and NF-κB activation. Eur J Endocrinol. 2012;166(4):743-752.
59. De Luca F, Barnes KM, Uyeda JA, et al. Regulation of growth plate chondrogenesis by bone morphogenetic protein-2. Endocrinology. 2001;142:430-436.
60. Li H, Bartold PM, Zhang CZ, Clarkson RW, Young WG, Waters MJ. Growth hormone and insulin-like growth factor I induce bone morphogenetic proteins 2 and 4: a mediator role in bone and tooth formation? Endocrinology. 1998;139:3855-3862.